Nutriband Inc
NASDAQ:NTRB 10:12:55 AM EDT
| Market Cap (Intraday) | 33.26M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.00 |
| 50-Day MA | $4.00 |
| 200-Day MA | N/A |
Nutriband Inc Stock, NASDAQ:NTRB
121 South Orange Avenue, Suite 1500, Orlando, Florida 32801
United States of America
Phone: +1.407.377.6695
Number of Employees: 13
Description
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.